DECISION OF THE EEA JOINT COMMITTEE

No 18/2016

of 5 February 2016

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2017/1301]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,

Whereas:

(1)	Commission Implementing Regulation (EU) 2015/1981 of 4 November 2015 approving Formaldehyde released from N,N-Methylenebismorpholine as an existing active substance for use in biocidal products for product-types 6 and 13 (1) is to be incorporated into the EEA Agreement.

(2)	Commission Implementing Regulation (EU) 2015/1982 of 4 November 2015 approving hexaflumuron as an existing active substance for use in biocidal products for product-type 18 (2) is to be incorporated into the EEA Agreement.

(3)	Commission Implementing Decision (EU) 2015/1985 of 4 November 2015 pursuant to Article 3(3) of Regulation (EU) No 528/2012 of the European Parliament and of the Council on an anti-viral tissue impregnated with citric acid (3) is to be incorporated into the EEA Agreement.

(4)	Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

The following points are inserted after point 12nns (Commission Implementing Regulation (EU) 2015/1759) of Chapter XV of Annex II to the EEA Agreement:

‘12nnt.

32015 R 1981: Commission Implementing Regulation (EU) 2015/1981 of 4 November 2015 approving Formaldehyde released from N,N-Methylenebismorpholine as an existing active substance for use in biocidal products for product-types 6 and 13 (OJ L 289, 5.11.2015, p. 9).

12nnu.

32015 R 1982: Commission Implementing Regulation (EU) 2015/1982 of 4 November 2015 approving hexaflumuron as an existing active substance for use in biocidal products for product-type 18 (OJ L 289, 5.11.2015, p. 13).

12nnv.

32015 D 1985: Commission Implementing Decision (EU) 2015/1985 of 4 November 2015 pursuant to Article 3(3) of Regulation (EU) No 528/2012 of the European Parliament and of the Council on an anti-viral tissue impregnated with citric acid (OJ L 289, 5.11.2015, p. 26).’

Article 2

The texts of Implementing Regulations (EU) 2015/1981 and (EU) 2015/1982 and Implementing Decision (EU) 2015/1985 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3

This Decision shall enter into force on 6 February 2016, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 5 February 2016.

For the EEA Joint Committee

The President

Claude MAERTEN

(1) OJ L 289, 5.11.2015, p. 9.

(2) OJ L 289, 5.11.2015, p. 13.

(3) OJ L 289, 5.11.2015, p. 26.

(*1) No constitutional requirements indicated.